Relaxation techniques for anxiety and sleep in COPD patients
Official title: Effects of Laura Mitchell's and Benson Relaxation Technique On Anxiety, Sleep Quality and Fatigue Among COPD Patients
Run by Riphah International University · NCT07635446 · Data updated 2026-11-12
This study tests whether Laura Mitchell’s relaxation technique or Benson’s relaxation response can help reduce anxiety, improve sleep, and lessen fatigue in adults with COPD.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 60 Years |
| Sex | All |
| Enrollment | 38 (estimated) |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Lahore, Punjab Province) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | August 1, 2026 |
| Study ends | August 1, 2026 |
| Registry record updated | June 9, 2026 |
| Trial ID | NCT07635446 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40-60 with a COPD diagnosis, without recent exacerbations, who are willing to participate.
✕Probably not a fit
Patients with recent COPD exacerbations or significant comorbidities may not experience benefit from these relaxation techniques.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares two relaxation methods in adults with moderate to severe COPD. Participants will be assigned to either Laura Mitchell's physiological relaxation technique or Benson's relaxation response to assess changes in anxiety, sleep quality, and fatigue. The study uses non-pharmacologic, simple techniques that can be performed without specialized equipment, aiming to identify which method provides greater psychological and fatigue-related benefits. Outcomes will inform non-drug approaches to improving quality of life for COPD patients. The trial is conducted at Gulab Devi Hospital in Lahore, with Riphah International University as the lead sponsor.
Why it matters
Potential benefit: If successful, participants may experience reduced anxiety and fatigue and improved sleep quality.
How similar studies have gone: Relaxation-based approaches have shown promise in improving anxiety and sleep in COPD and other chronic conditions, though direct comparisons of these two methods are less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Gender: Male and Female * Age: 40 to 60 years * Patients diagnosed with COPD * Willing to participate Exclusion Criteria: * Patients with Exacerbations within past 4 weeks * Cardiac Diseases (Acute MI, Congestive Heart Failure) * Neuromuscular Disorder * Recent lung diseases * Hemodynamic instability * Respiratory failure
Where it's running
-
Gulab Devi Hospital
Lahore, Punjab Province, Pakistan Recruiting
Study contacts
- Principal investigator: Arjumand Bano, MS — Riphah International University
- Study coordinator: Muhammad Iqbal Tariq, Phd
- Email: iqbal.tariq@riphah.edu.pk
- Phone: 333826752
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.